D
Altimmune, Inc. ALT
$3.93 $0.000.00% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Revenue 0.00% 0.00% -86.49% -98.62% -16.67%
Total Other Revenue -- -- -- -- --
Total Revenue 0.00% 0.00% -86.49% -98.62% -16.67%
Cost of Revenue -18.53% -26.34% 16.99% 7.70% 59.62%
Gross Profit 18.53% 26.35% -17.21% -9.83% -59.66%
SG&A Expenses 1.72% 12.82% 17.50% 10.08% 17.54%
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses -14.29% -18.58% 17.09% 8.17% 48.50%
Operating Income 14.29% 18.58% -17.27% -9.88% -48.53%
Income Before Tax 10.12% 16.96% 26.74% -10.52% -53.42%
Income Tax Expenses -- -- -- -- --
Earnings from Continuing Operations 10.12% 19.75% 26.74% -10.52% -53.42%
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income 10.12% 19.75% 26.74% -10.52% -53.42%
EBIT 14.29% 18.58% -17.27% -9.88% -48.53%
EBITDA 14.21% 18.36% -17.75% -10.31% -49.22%
EPS Basic 21.76% 24.79% 39.92% 16.61% -9.66%
Normalized Basic EPS 21.74% 22.16% 1.12% 16.60% -9.65%
EPS Diluted 21.76% 24.79% 39.92% 16.61% -9.66%
Normalized Diluted EPS 21.74% 22.16% 1.12% 16.60% -9.65%
Average Basic Shares Outstanding 14.88% 6.70% 21.93% 32.54% 39.91%
Average Diluted Shares Outstanding 14.88% 6.70% 21.93% 32.54% 39.91%
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --